Scholarlink

<p>Oxidative stress induced by NOX4 overactivation plays a central role in podocyte injury during diabetic nephropathy (DN). In this study, a multifunctional Emodin-loaded nanoparticle system (Emodin-NPs) was designed to target NOX4 and alleviate oxidative damage. The delivery platform was constructed using dendritic mesoporous silica nanoparticles (DMSNs) coated with hyaluronic acid (HA) to enhance cellular targeting. Furthermore, HA was modified with a π-conjugated compound (compound 1) and a green tea–derived bioactive molecule (compound 2), aiming to improve the electrochemical responsiveness and stability of the nanocarrier. Comprehensive characterization confirmed the successful synthesis of the composite material, 1-HA-2@DMSNs@Emodin, which exhibited favorable electrochemical behavior and stable physicochemical properties. In vitro experiments using mouse podocyte MPC5 cells demonstrated that Emodin-NPs significantly alleviated high-glucose-induced injury by enhancing cell viability, downregulating NOX4 mRNA expression, and reducing IL-6 secretion. This work provides a promising and biocompatible nanoplatform for redox-responsive drug delivery and offers a potential strategy for the treatment of diabetic nephropathy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Electrochemically Responsive Hyaluronic Acid–Functionalized Dendritic Silica Nanoplatform for Delivery of Emodin in Diabetic Nephropathy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月18日

查看全文
  • Xiaoming Jiang,
  • Huan Qi,
  • Jue’an Jiang,
  • Liqiang Yu

摘要

Oxidative stress induced by NOX4 overactivation plays a central role in podocyte injury during diabetic nephropathy (DN). In this study, a multifunctional Emodin-loaded nanoparticle system (Emodin-NPs) was designed to target NOX4 and alleviate oxidative damage. The delivery platform was constructed using dendritic mesoporous silica nanoparticles (DMSNs) coated with hyaluronic acid (HA) to enhance cellular targeting. Furthermore, HA was modified with a π-conjugated compound (compound 1) and a green tea–derived bioactive molecule (compound 2), aiming to improve the electrochemical responsiveness and stability of the nanocarrier. Comprehensive characterization confirmed the successful synthesis of the composite material, 1-HA-2@DMSNs@Emodin, which exhibited favorable electrochemical behavior and stable physicochemical properties. In vitro experiments using mouse podocyte MPC5 cells demonstrated that Emodin-NPs significantly alleviated high-glucose-induced injury by enhancing cell viability, downregulating NOX4 mRNA expression, and reducing IL-6 secretion. This work provides a promising and biocompatible nanoplatform for redox-responsive drug delivery and offers a potential strategy for the treatment of diabetic nephropathy.